These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23506481)

  • 1. Milnacipran for fibromyalgia: a useful addition to the treatment armamentarium.
    Bernstein CD; Albrecht KL; Marcus DA
    Expert Opin Pharmacother; 2013 May; 14(7):905-16. PubMed ID: 23506481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia.
    Welsch P; Üçeyler N; Klose P; Walitt B; Häuser W
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD010292. PubMed ID: 29489029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical potential of milnacipran, a serotonin and norepinephrine reuptake inhibitor, in pain.
    Leo RJ; Brooks VL
    Curr Opin Investig Drugs; 2006 Jul; 7(7):637-42. PubMed ID: 16869117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Milnacipran for fibromyalgia.
    Dempsey J
    Issues Emerg Health Technol; 2008 Feb; (114):1-4. PubMed ID: 18354855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia syndrome.
    Häuser W; Urrútia G; Tort S; Uçeyler N; Walitt B
    Cochrane Database Syst Rev; 2013 Jan; (1):CD010292. PubMed ID: 23440848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Between depression and fibroniyalgia: the fate of the antidepressant].
    Drobizhev MY; Fedotova AV; Kikta SV; Antokhin EY
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):114-120. PubMed ID: 27386594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Milnacipran: beyond a role of antidepressant.
    Pae CU; Marks DM; Shah M; Han C; Ham BJ; Patkar AA; Masand PS
    Clin Neuropharmacol; 2009; 32(6):355-63. PubMed ID: 19620845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milnacipran and selective serotonin reuptake inhibitors in major depression.
    Lopez-Ibor J; Guelfi JD; Pletan Y; Tournoux A; Prost JF
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():41-6. PubMed ID: 8923126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milnacipran for neuropathic pain and fibromyalgia in adults.
    Derry S; Gill D; Phillips T; Moore RA
    Cochrane Database Syst Rev; 2012 Mar; 3(3):CD008244. PubMed ID: 22419330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
    Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
    Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia.
    Jensen KB; Petzke F; Carville S; Choy E; Fransson P; Gracely RH; Vitton O; Marcus H; Williams SC; Ingvar M; Kosek E
    J Pain; 2014 Dec; 15(12):1328-37. PubMed ID: 25283470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Serotonin-noradrenaline reuptake inhibitors(SNRIs)].
    Ishigooka J
    Nihon Rinsho; 2001 Aug; 59(8):1523-9. PubMed ID: 11519152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Natelson BH; Vu D; Mao X; Weiduschat N; Togo F; Lange G; Blate M; Kang G; Coplan JD; Shungu DC
    J Pain; 2015 Nov; 16(11):1211-9. PubMed ID: 26335989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies with milnacipran and tricyclic antidepressants in the treatment of patients with major depression: a summary of clinical trial results.
    Kasper S; Pletan Y; Solles A; Tournoux A
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():35-9. PubMed ID: 8923125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of milnacipran in patients with fibromyalgia.
    Gendreau RM; Thorn MD; Gendreau JF; Kranzler JD; Ribeiro S; Gracely RH; Williams DA; Mease PJ; McLean SA; Clauw DJ
    J Rheumatol; 2005 Oct; 32(10):1975-85. PubMed ID: 16206355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current progress in the pharmacological therapy of fibromyalgia.
    Rao SG
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1479-93. PubMed ID: 19732029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACS chemical neuroscience molecule spotlight on savella.
    Hopkins CR
    ACS Chem Neurosci; 2010 May; 1(5):345. PubMed ID: 22778830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic effects of milnacipran (serotonin noradrenalin reuptake inhibitor) on depression following mild and moderate traumatic brain injury.
    Kanetani K; Kimura M; Endo S
    J Nippon Med Sch; 2003 Aug; 70(4):313-20. PubMed ID: 12928711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and tolerability of milnacipran: an overview.
    Montgomery SA; Prost JF; Solles A; Briley M
    Int Clin Psychopharmacol; 1996 Sep; 11 Suppl 4():47-51. PubMed ID: 8923127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Milnacipran for treatment of fibromyalgia.
    Kyle JA; Dugan BD; Testerman KK
    Ann Pharmacother; 2010 Sep; 44(9):1422-9. PubMed ID: 20716692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.